MedPeer (6095.T) Stock Price

MedPeer Price

Delisted

Over the last 15 years MedPeer grew revenue by 45.4% annually, reaching 14.95 B JPY. Earnings per share have grown at 37.4% per year over the last 12 years. For MedPeer, the net margin of 9.9% is down versus 13.7% a few years ago. The payout ratio is around 7% of earnings.

MedPeer stock price

Volume
Ex-Dividend
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of MedPeer over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how MedPeer stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing MedPeer's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

MedPeer Stock Price History
DateMedPeer Price
Access this data via the Eulerpool API

MedPeer Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
5.31 B JPY
1.10 B JPY
725.97 M JPY
Jan 1, 2021
7.44 B JPY
1.78 B JPY
1.29 B JPY
Jan 1, 2022
8.45 B JPY
1.06 B JPY
812.39 M JPY
Jan 1, 2023
14.54 B JPY
1.12 B JPY
617.68 M JPY
Jan 1, 2024
14.95 B JPY
1.29 B JPY
1.48 B JPY
Jan 1, 2025 (e)
12.49 B JPY
0.00 JPY
536.10 M JPY
Jan 1, 2026 (e)
13.40 B JPY
0.00 JPY
681.91 M JPY
Jan 1, 2027 (e)
14.12 B JPY
0.00 JPY
859.51 M JPY

MedPeer Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 24, 2026, 8:15 PM
 
REVENUEB JPY
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB JPY
EBITB JPY
EBIT MARGIN%
NET INCOMEB JPY
NET INCOME GROWTH%
DIV.JPY
DIV. GROWTH%
SHARESM
20122013201420152016201720182019202020212022202320242025e2026e2027e
0.320.570.961.040.971.562.203.055.317.448.4514.5414.9512.4913.4014.12
134.7877.1666.908.46-6.3560.2341.0538.4774.4239.9913.6872.032.81-16.447.295.40
83.3386.0688.7385.6677.2975.4374.1769.5266.0165.2959.5547.2245.9745.9745.9745.97
0.270.490.850.890.751.181.632.123.514.855.036.876.875.746.166.49
0.020.090.260.140.060.080.370.561.101.781.061.121.29
6.7915.5127.5613.095.865.2616.6918.3320.7923.9812.587.708.64
0.020.110.150.070.02-0.360.210.390.731.290.810.621.480.540.680.86
-125.88413.6432.74-53.33-67.14-1,678.26-156.7591.2684.0178.34-37.20-24.01140.03-63.8127.0526.14
4.509.009.009.009.00
100.00
14.7014.7015.9017.9317.7517.3818.3219.9122.2223.0022.7022.0721.7121.7121.7121.71
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales MedPeer generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue MedPeer retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare MedPeer's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares MedPeer has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against MedPeer's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

MedPeer stock margins

The MedPeer margin analysis displays the gross margin, EBIT margin, as well as the profit margin of MedPeer. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for MedPeer.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
66.02 %
20.80 %
13.67 %
Jan 1, 2021
65.29 %
23.99 %
17.40 %
Jan 1, 2022
59.56 %
12.59 %
9.61 %
Jan 1, 2023
47.22 %
7.70 %
4.25 %
Jan 1, 2024
45.97 %
8.64 %
9.91 %
Jan 1, 2025 (e)
45.97 %
0.00 %
4.29 %
Jan 1, 2026 (e)
45.97 %
0.00 %
5.09 %
Jan 1, 2027 (e)
45.97 %
0.00 %
6.09 %

MedPeer Stock Revenue, EBIT, Earnings per Share

The MedPeer earnings per share therefore indicates how much revenue MedPeer has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
984.30 M JPY
204.77 M JPY
134.54 M JPY
Jan 1, 2021
1.33 B JPY
319.46 M JPY
231.63 M JPY
Jan 1, 2022
1.53 B JPY
192.95 M JPY
147.36 M JPY
Jan 1, 2023
2.71 B JPY
208.98 M JPY
115.25 M JPY
Jan 1, 2024
2.84 B JPY
244.99 M JPY
281.09 M JPY
Jan 1, 2025 (e)
2.37 B JPY
0.00 JPY
101.70 M JPY
Jan 1, 2026 (e)
2.54 B JPY
0.00 JPY
129.36 M JPY
Jan 1, 2027 (e)
2.68 B JPY
0.00 JPY
163.05 M JPY

MedPeer business model & stock analysis

MedPeer Inc is a US-American company that was founded in Boston, Massachusetts in 2004. The company develops and operates social networks and platforms for doctors and medical students. The business model of MedPeer is focused on bringing doctors and medical students together on a platform where they can exchange medical information, ask and answer questions, and engage in discussions on current medical topics. MedPeer is primarily a platform that provides information and support to medical professionals and facilitates the exchange of valuable information. MedPeer also offers various specialized sections that provide specific information and support to doctors and medical students. These sections include, among others, gastroenterology, cardiology, oncology, neurology, dermatology, and mental health. In the field of gastroenterology, MedPeer provides information on the diagnosis and treatment of gastrointestinal diseases. In the field of cardiology, MedPeer provides information on the diagnosis and treatment of cardiovascular diseases. In the field of oncology, MedPeer provides information on cancer treatment. In the field of neurology, MedPeer provides information on the treatment of neurological diseases such as Alzheimer's, Parkinson's, and multiple sclerosis. In the field of dermatology, MedPeer provides information on the diagnosis and treatment of skin diseases. In the field of mental health, MedPeer provides information on the diagnosis and treatment of mental illnesses such as depression and anxiety. MedPeer also offers products that are designed to assist doctors and medical students in their work and studies. An example of this is the MedPeer Academy course, which prepares medical students for their clinical rotations and prepares them for the exam they must take at the end of their rotation period. Other products offered by MedPeer include digital medical libraries that provide access to thousands of medical articles, journals, and textbooks. Additionally, MedPeer offers various software tools designed to assist doctors in the diagnosis and treatment of patients. Over the years, MedPeer has received several awards and recognitions, including first place in the "Medical Services and Equipment" category at the Global Mobile Awards 2014. Furthermore, the company has received a significant amount of venture capital investments in recent years. The company has also recently entered into a partnership with Allm, a Japanese provider of mobile and web applications for the healthcare sector. The partnership aims to allow MedPeer to enter the Japanese market and expand its services and products to a larger audience. Overall, MedPeer has made significant progress in recent years and has become a key player in the medical information and communication industry. The company has demonstrated its ability to provide high-quality products and services that can assist doctors and medical students in their work and studies.

MedPeer SWOT Analysis

Strengths

MedPeer Inc possesses several strengths that contribute to its success in the market. These include:

  • Established brand presence and reputation in the industry
  • Advanced technology platform for connecting medical professionals
  • Wide network of healthcare providers and experts
  • Strong financial position and steady revenue growth
  • Comprehensive range of services and products for medical professionals
  • Effective marketing and customer acquisition strategies

Weaknesses

Despite its strengths, MedPeer Inc also faces certain weaknesses that can hinder its performance. These weaknesses include:

  • Heavy reliance on the Japanese market, limiting international expansion opportunities
  • Limited diversification of service offerings beyond medical networking
  • Dependence on key partnerships for content and data provision
  • Challenges in maintaining user engagement and active participation
  • Limited visibility and recognition in global markets

Opportunities

MedPeer Inc has potential opportunities that can drive its growth and expansion. These opportunities include:

  • Expansion into international markets to tap into a larger user base
  • Diversification of services to include telemedicine and remote consultations
  • Collaboration with pharmaceutical companies for research and development
  • Incorporation of artificial intelligence and machine learning in data analysis
  • Expansion into related healthcare sectors, such as medical education and training

Threats

MedPeer Inc faces certain threats that can impact its business operations and market position. These threats include:

  • Competition from existing and emerging medical networking platforms
  • Regulatory changes and compliance requirements affecting healthcare data privacy
  • Economic downturn or instability impacting healthcare spending
  • Emergence of disruptive technologies or business models in the healthcare industry
  • Potential reputational damage due to data breaches or privacy concerns

MedPeer Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

MedPeer historical P/E ratio, EBIT multiple, and P/S ratio

MedPeer annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

MedPeer shares outstanding

The number of shares of MedPeer was 5.27 in 2025. This indicates how many shares MedPeer is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
5.40 Stocks
Jan 1, 2021
5.58 Stocks
Jan 1, 2022
5.51 Stocks
Jan 1, 2023
5.36 Stocks
Jan 1, 2024
5.27 Stocks
Jan 1, 2025 (e)
5.27 Stocks
Jan 1, 2026 (e)
5.27 Stocks
Jan 1, 2027 (e)
5.27 Stocks

MedPeer stock splits

In MedPeer's history, there have been no stock splits.

MedPeer Dividend History

3 years of dividend payments

YearAnnual DividendYoY ChangePayments
20254.50JPY 0.0%
Sep 29, 20254.50JPY 0.0%1/1
20244.50JPY 0.0%
20234.50JPY

MedPeer dividend history and estimates

In 2025, MedPeer paid a dividend amounting to 9.00 JPY. Dividend means that MedPeer distributes a portion of its profits to its owners.
  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2023 (e)
0.00 JPY
4.50 JPY
Jan 1, 2024 (e)
4.50 JPY
4.50 JPY
Jan 1, 2025
9.00 JPY
0.00 JPY
Jan 1, 2026 (e)
0.00 JPY
9.00 JPY
Jan 1, 2027 (e)
0.00 JPY
9.00 JPY

MedPeer dividend payout ratio

In 2025, MedPeer had a payout ratio of 36.45%. The payout ratio indicates the percentage of the company's profits that MedPeer distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2020
11.34 %
Jan 1, 2021
11.34 %
Jan 1, 2022
11.34 %
Jan 1, 2023
16.08 %
Jan 1, 2024
6.59 %
Jan 1, 2025 (e)
36.45 %
Jan 1, 2026 (e)
28.65 %
Jan 1, 2027 (e)
22.73 %
Price targets and forecasts for MedPeer are not yet available.

MedPeer shareholder structure

% Name
63.01145%
NMT, Inc.
NMT, Inc.
13.22188%
Iwami (Yo)
Iwami (Yo)
5.75793%
Bozo KK
Bozo KK
1.06794%
Nikko Asset Management Co., Ltd.
Nikko Asset Management Co., Ltd.
1.02109%
Daiwa Asset Management Co., Ltd.
Daiwa Asset Management Co., Ltd.
0.32271%
Mitsubishi UFJ Asset Management Co., Ltd.
Mitsubishi UFJ Asset Management Co., Ltd.

MedPeer Executives and Management Board

YI

Mr. Yo Iwami

(50)

Chairman of the Board · since 2005

NG

Mr. Naoki Goto

(36)

Executive President, Chief Executive Officer, Representative Director · since 2023

TH

Mr. Toshio Hirabayashi

(43)

Executive Officer, Chief Financial Officer, Director · since 2018

TT

Mr. Takuma Tsuzuki

Executive Officer, Chief Operating Officer

YY

Mr. Yutaro Yamagiwa

Executive Officer, Chief Human Resource Officer

MedPeer Supply Chain

MedPeer Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
6 companies
#Name1M3M6M1Y2YTrend
1
-0.46
0.42
0.44
0.41
0.54
#Name1M3M6M1Y2YTrend
1
INTAGE
Supplier
0.91
0.62
0.41
-0.18
-0.38
2
0.39
0.44
0.32
0.42
-0.12
3
Sugi
Supplier
0.86
0.49
0.33
0.67
0.24
4
0.84
0.65
0.41
0.61
0.27
5
0.88
0.84
0.60
0.46
0.28

Frequently asked questions about MedPeer

MedPeer Inc is primarily present in Japan. As a professional stock website, we provide comprehensive information about various stocks, including MedPeer Inc. MedPeer Inc is a leading medical networking platform operating primarily in Japan. With its innovative services, MedPeer Inc aims to enhance collaboration among medical professionals and promote knowledge sharing within the healthcare industry. Although MedPeer Inc's presence may expand in the future, currently, its primary focus is on the Japanese market. Stay updated on MedPeer Inc's latest developments and stock information with our website.

All fundamentals and in-depth analysis of MedPeer

Our stock analysis for MedPeer stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MedPeer. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.